Clinical Trial Update: Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on biomarkers of activity and efficacy for BIBW2992 in untreated non-metastatic head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma Squamous Cell of Head and Neck

Drugs mentioned

• BIBW2992

Snippet

Sponsor: UNICANCER | Conditions: Carcinoma, Squamous Cell of Head and Neck | Phase 2 | Status: COMPLETED